Andrew D. Pearle, MD, Named Next Chief of the Sports Medicine Institute at HSS
Hospital for Special Surgery (HSS), the world’s largest academic medical center focused on musculoskeletal health, today announced that Andrew D. Pearle, MD, will succeed Bryan T. Kelly, MD, as chief of the HSS Sports Medicine Institute. Dr. Kelly was recently appointed Surgeon-in-Chief and Medical Director of HSS. Both physicians will assume their new roles on July 1. HSS has been the nation’s top-ranked hospital for Orthopedics for the past nine consecutive years according to U.S.News & World Report, and is a world leader in sports medicine, performance and rehabilitation.
Within HSS, the Sports Medicine Institute fulfills the mission of developing an internationally renowned and multidisciplinary program that offers the best evidence-based clinical care for athletes across the world. Current locations include the HSS Main Campus on the Upper East Side of Manhattan, and HSS Outpatient Centers in Paramus, NJ; White Plains, NY; Stamford, CT; and Uniondale, NY. The Sports Medicine Institute will be part of four new HSS facilities opening in the coming months on the West Side of Manhattan, at Hudson Yards, in Brooklyn, and in West Palm Beach, Florida.
A graduate of Amherst College and Stanford Medical School, Dr. Pearle started at HSS in 1998 as a surgical intern and began his medical practice there in 2005. He currently practices at the HSS main campus in New York City, and at HSS Westchester where he serves as Medical Director. In addition to his responsibilities at HSS, Dr. Pearle is Head Team Orthopedic Surgeon for Rugby United New York, an Associate Team Physician for the New York Mets, and helps coordinate care for the Mets' minor league affiliates including the Brooklyn Cyclones.
“We are fortunate to have an extremely talented team of physicians and surgeons in the HSS Sports Medicine Institute who are dedicated to advancing the diagnosis and treatment of sports injuries,” said Dr. Kelly. “Dr. Pearle embodies what it means to be an HSS physician and leader, with exceptional capability and commitment to delivering the highest quality patient care, supporting education, and improving surgical outcomes.”
Dr. Pearle specializes in knee and shoulder surgery, and is recognized internationally for his pioneering work in robotic knee surgery. He developed one of the first Computer Assisted Surgery programs in the United States, and in 2007 performed the first robotic partial knee replacement in the New York region.
“HSS has a special responsibility and opportunity to lead the global advancement, impact and availability of the highest quality musculoskeletal care, and within this Dr. Pearle is well suited to lead the essential role of the Sports Medicine Institute,” said Louis A. Shapiro, President and CEO, HSS.
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 14th consecutive year), No. 2 in rheumatology by U.S. News & World Report (2023-2024), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report “Best Children’s Hospitals” list (2023-2024). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a third consecutive year (2023). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnosis, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.